Legal Representation
Attorney
Carla B. Oakley
USPTO Deadlines
Next Deadline
2127 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251028)
Due Date
October 28, 2031
Grace Period Ends
April 28, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 28, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 28, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 9, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Oct 9, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Sep 18, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 25, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 18, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 25, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 18, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 21, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 21, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 15, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 30, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 11, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 10, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 10, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 11, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 11, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 11, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 10, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 24, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 19, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Selective cytopheretic devices, namely medical devices used to treat conditions caused by a dysregulated immune response by selectively binding certain activated white blood cells, reducing their inflammatory state, and releasing the modified blood cells back into the blood.
First Use Anywhere:
Jul 31, 2024
First Use in Commerce:
Jul 31, 2024
Additional Information
Translation
The wording "Quelimmune" has no meaning in a foreign language.
Classification
International Classes
010